These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28351678)

  • 1. The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice.
    Dickie AP; Wilson CE; Schreiter K; Wehr R; Wilson EM; Bial J; Scheer N; Wilson ID; Riley RJ
    Biochem Pharmacol; 2017 Jul; 135():139-150. PubMed ID: 28351678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and metabolism of diclofenac in chimeric humanized and murinized FRG mice.
    Wilson CE; Dickie AP; Schreiter K; Wehr R; Wilson EM; Bial J; Scheer N; Wilson ID; Riley RJ
    Arch Toxicol; 2018 Jun; 92(6):1953-1967. PubMed ID: 29721588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumiracoxib metabolism in male C57bl/6J mice: characterisation of novel in vivo metabolites.
    P Dickie A; Wilson CE; Schreiter K; Wehr R; D Wilson I; Riley R
    Xenobiotica; 2017 Jun; 47(6):538-546. PubMed ID: 27430634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone metabolism and transporter effects in chimeric mice: a comparison between chimeric humanized and chimeric murinized FRG mice.
    Samuelsson K; Pickup K; Sarda S; Foster JR; Randall K; Abrahamsson A; Jacobsen M; Weidolf L; Wilson I
    Xenobiotica; 2014 Jan; 44(2):186-95. PubMed ID: 24417752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the accumulative human metabolite and human-specific glutathione conjugate of diclofenac in TK-NOG chimeric mice with humanized livers.
    Kamimura H; Ito S; Nozawa K; Nakamura S; Chijiwa H; Nagatsuka S; Kuronuma M; Ohnishi Y; Suemizu H; Ninomiya S
    Drug Metab Dispos; 2015 Mar; 43(3):309-16. PubMed ID: 25504502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated high-performance liquid chromatographic assay for determination of lumiracoxib in human plasma.
    Cheremina O; Brune K; Hinz B
    Biomed Chromatogr; 2006 Oct; 20(10):1033-7. PubMed ID: 16602135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diclofenac metabolism in the mouse: novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry.
    Sarda S; Page C; Pickup K; Schulz-Utermoehl T; Wilson I
    Xenobiotica; 2012 Feb; 42(2):179-94. PubMed ID: 21955289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitor.
    Rordorf CM; Choi L; Marshall P; Mangold JB
    Clin Pharmacokinet; 2005; 44(12):1247-66. PubMed ID: 16372823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.
    Ekdahl A; Weidolf L; Baginski M; Morikawa Y; Thompson RA; Wilson ID
    Arch Toxicol; 2018 Sep; 92(9):2819-2828. PubMed ID: 30094548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects.
    Mangold JB; Gu H; Rodriguez LC; Bonner J; Dickson J; Rordorf C
    Drug Metab Dispos; 2004 May; 32(5):566-71. PubMed ID: 15100180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling.
    Miyaguchi T; Suemizu H; Shimizu M; Shida S; Nishiyama S; Takano R; Murayama N; Yamazaki H
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):71-6. PubMed ID: 25805149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolic activation of lumiracoxib in rat and human liver preparations.
    Li Y; Slatter JG; Zhang Z; Li Y; Doss GA; Braun MP; Stearns RA; Dean DC; Baillie TA; Tang W
    Drug Metab Dispos; 2008 Feb; 36(2):469-73. PubMed ID: 17998295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of circulating human metabolites of pemafibrate, a novel antidyslipidemic drug, using chimeric mice with humanized liver.
    Ogawa SI; Uehara S; Tsunenari Y; Kawai H; Suemizu H; Yamazaki H
    Xenobiotica; 2020 Jul; 50(7):769-775. PubMed ID: 31766940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans.
    Nakada N; Oda K
    Xenobiotica; 2015; 45(9):757-65. PubMed ID: 25869242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: application to the metabolism of diclofenac.
    Pickup K; Gavin A; Jones HB; Karlsson E; Page C; Ratcliffe K; Sarda S; Schulz-Utermoehl T; Wilson I
    Xenobiotica; 2012 Feb; 42(2):195-205. PubMed ID: 21955249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumiracoxib.
    Buvanendran A; Barkin R
    Drugs Today (Barc); 2007 Mar; 43(3):137-47. PubMed ID: 17380211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.
    Esser R; Berry C; Du Z; Dawson J; Fox A; Fujimoto RA; Haston W; Kimble EF; Koehler J; Peppard J; Quadros E; Quintavalla J; Toscano K; Urban L; van Duzer J; Zhang X; Zhou S; Marshall PJ
    Br J Pharmacol; 2005 Feb; 144(4):538-50. PubMed ID: 15655513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib, an oral COX-2 selective inhibitor.
    Kalbag J; Yeh CM; Milosavljev S; Lasseter K; Oberstein S; Rordorf C
    Pharmacol Res; 2004 Aug; 50(2):181-6. PubMed ID: 15177307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.